Tirzepatide: SURMOUNT trial program The SURMOUNT-1 trial (2022) evaluated tirzepatide 5 mg, 10 mg, and 15 mg versus placebo in non-diabetic adults with obesity over 72 weeks
Contact your provider immediately if you experience severe abdominal pain, persistent vomiting, signs of kidney problems, or significant changes in health status
Most research evaluates each intervention independentlysemaglutide studies focus on weight loss, blood sugar control, and cardiovascular outcomes, while NAD research explores aging, longevity, and metabolic disease
19 The researchers looked at records of over 3.8 million patients who had type 2 diabetes to assess the time to development of NAION after initiation of GLP-1 treatment
Researchers looked at data from more than 430,000 patients aged 50 and older who took either a GLP-1, sodium-glucose cotransporter 2 inhibitors (SGLT2i), metformin or insulin to manage their diabetes for at least two years
HGH should be taken on an empty stomach, ideally at least 2 hours after eating